(Q37181154)

18 August 2017

title

Further experience with the use of 6-thioguanine in patients with Crohn's disease (English)

1 reference

18 August 2017

0 references

1 reference

Azhar Ansari

1

1 reference

18 August 2017

Tim Elliott

2

1 reference

18 August 2017

Farina Fong

3

1 reference

18 August 2017

Monica Arenas-Hernandez

4

1 reference

18 August 2017

Giles Rottenberg

5

1 reference

18 August 2017

Bernard Portmann

6

1 reference

18 August 2017

Sebastian Lucas

7

1 reference

18 August 2017

Anthony Marinaki

8

1 reference

18 August 2017

Jeremy Sanderson

9

1 reference

18 August 2017

publication date

1 October 2008

1 reference

Inflammatory Bowel Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

14

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

1399-1405

1 reference

Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease

18 August 2017

cites work

1 reference

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

21 January 2018

1 reference

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension

21 January 2018

1 reference

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

21 January 2018

1 reference

6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.

21 January 2018

1 reference

Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection

21 January 2018

1 reference

Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

21 January 2018

1 reference

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

21 January 2018

1 reference

Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients

21 January 2018

1 reference

Hepatotoxicity of chemotherapy

21 January 2018

1 reference

Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience

21 January 2018

1 reference

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

21 January 2018

1 reference

Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation

21 January 2018

1 reference

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides

21 January 2018

1 reference

Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods

21 January 2018

1 reference

A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine

21 January 2018

1 reference

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20492

1 reference

release_naq73qc5lbalrd5dn6v632xpqy

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/naq73qc5lbalrd5dn6v632xpqy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference